SCHEMBL8770856

SCHEMBL8770856

COc1cccc(C(=O)Nc2ccc(-c3nnc(-c4ccc(NC(=O)c5cccc(OC)c5)cc4)o3)cc2)c1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.83
ALDH1A1 P00352 5/20 0.83
HPGD P15428 5/20 0.83
MAPT P10636 5/20 0.83
NPSR1 Q6W5P4 2/20 0.83
CYP3A4 P08684 1/20 0.83
CYP2C9 P11712 1/20 0.83
CYP2C19 P33261 1/20 0.83
HIF1A Q16665 1/20 0.83
TSHR P16473 3/20 0.78
ALOX15 P16050 2/20 0.78
HSD17B10 Q99714 2/20 0.78
ADCY1 Q08828 1/20 0.69
KMT2A Q03164 5/20 0.69
MEN1 O00255 4/20 0.69
LMNA P02545 2/20 0.69
LCLAT1 Q6UWP7 1/20 0.69
NPC1 O15118 6/20 0.67
RAB9A P51151 6/20 0.67
SMN1; SMN2 Q16637 5/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16383848 0.91 MAPT (1.00) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL8770851 0.84 LCLAT1 (0.68) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL6802217 0.83 NPC1 (0.83) KDM4EALDH1A1HPGDTSHRKMT2A
SCHEMBL16384042 0.82 LCLAT1 (1.00) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL20598520 0.82 ADCY1 (1.00) KDM4EMAPTADCY1KMT2AMEN1
SCHEMBL24473976 0.82 RAB9A (0.68) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL26078548 0.82 NPC1 (0.68) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL7701071 0.81 TSHR (0.63) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL13878542 0.81 CHRNA7 (0.67) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL30587158 0.81 TSHR (0.67) KDM4EALDH1A1HPGDMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9622991-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2017-04-18 US disclosed
US-9144557-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2015-09-29 US disclosed
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2015-09-10 US disclosed
US-20120295904-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2012-11-22 US disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF KDM4E 1944/4885ALDH1A1 2736/4885HPGD 1328/4885
US-20120295904-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF KDM4E 1944/4885ALDH1A1 2736/4885HPGD 1328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.